All News

Study Finds Patients with HER2+ Breast Cancer Live Longer if Anti-Cancer Drugs Induce pCR
October 25, 2020

A study which evaluated lapatinib (Tykerb) and trastuzumab (Herceptin) given prior to surgery in patients with early HER2-positive breast cancer revealed that women who had a pathological complete response survived longer without the cancer returning than those who did not.

Tremelimumab, Durvalumab Combo Shows Promise for Certain Patients with Localized Bladder Cancer
October 25, 2020

Combination treatment with tremelimumab and durvalumab was found to be well-tolerated and showed early signs of activity in certain patients with localized bladder cancer who are not eligible for cisplatin-based chemotherapy.

Black Men with Prostate Cancer Treated with Radiation in VA Health System See Improved Outcomes
October 24, 2020

Black race was associated with improved prostate cancer-specific mortality and all-cause mortality among men with nonmetastatic prostate cancer who received radiation therapy in this large equal-access health care system.